Effectiveness of active case-finding strategies in tuberculosis control in Kampala, Uganda

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 2, 2013, Pages

  Mupere, Ezekiel ^a   Schiltz, N K ^b   Mulogo, E ^c   Katamba, A ^a   Nabbuye Sekandi, J ^a   Singer, M E ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

Active case finding; Life years saved; Passive case finding; Quality adjusted life years; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEATH; DECISION TREE; HEALTH PROGRAM; HUMAN; LIFE YEARS SAVED; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PEER REVIEW; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SCORING SYSTEM; STATISTICAL PARAMETERS; TUBERCULOSIS; TUBERCULOSIS CONTROL; UGANDA; URBAN AREA;

ADOLESCENT; ADULT; AGED; CHILD; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; FEMALE; HEALTH CARE COSTS; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; MORBIDITY; QUALITY-ADJUSTED LIFE YEARS; TUBERCULOSIS; UGANDA; YOUNG ADULT;

EID: 84872344616     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0160     Document Type: Article

References (35)

1. World Health Organization. Global tuberculosis control. WHO report 2011. WHO/HTM/TB/2011.16. Geneva, Switzerland: WHO, 2011.
2. Raviglione M C, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet 2002; 359: 775-780. (Pubitemid 34215081)
3. Kiwuwa M S, Charles K, Harriet M K. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. BMC Public Health 2005; 5: 122.
4. Golub J E, Mohan C I, Comstock G W, Chaisson R E. Active case-finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005; 9: 1183-1203. (Pubitemid 41735596)
5. Getahun H, Raviglione M. Active case-finding for TB in the community: time to act. Lancet 2010; 376: 1205-1206.
6. Corbett E L, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 2010; 376: 1244-1253.
7. den Boon S, Verver S, Lombard C J, et al. Comparison of symptoms and treatment outcomes between actively and passively detected tuberculosis cases: the additional value of active case finding. Epidemiol Infect 2008; 136: 1342-1349.
8. Yimer S, Holm-Hansen C, Yimaldu T, Bjune G. Evaluating an active case-finding strategy to identify smear-positive tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis 2009; 13: 1399-1404.
9. Sekandi J N, Neuhauser D, Smyth K, Whalen C C. Active case finding of undetected tuberculosis among chronic coughers in a slum setting in Kampala, Uganda. Int J Tuberc Lung Dis 2009; 13: 508-513.
10. Zachariah R, Spielmann M-P, Harries A D, et al. Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberc Lung Dis 2003; 7: 1033-1039. (Pubitemid 37376952)
11. Murray C J L, Salomon J A. Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding. Int J Tuberc Lung Dis 1998; 2 (Suppl 1): S9-S15.
12. Maher D, Hausler H P, Raviglione M C, et al. Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. Int J Tuberc Lung Dis 1997; 1: 276-283. (Pubitemid 127509661)
13. Uganda Ministry of Health. The National Tuberculosis and Leprosy Control Program manual. 2nd ed. Kampala, Uganda: MOH, 2010.
14. Jindani A, Nunn A J, Enarson D A. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004; 364: 1244-1251. (Pubitemid 39311345)
15. Levy H, Feldman C, Sacho H, van der Meulen H, Kallenbach J, Koornhof H. A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989; 95: 1193-1197. (Pubitemid 19160138)
16. Aber V R, Allen B W, Mitchison D A, Ayuma P, Edwards E A, Keyes A B. Quality control in tuberculosis bacteriology. 1. Laboratory studies on isolated positive cultures and the efficiency of direct smear examination. Tubercle 1980; 61: 123-133. (Pubitemid 10051995)
17. Wilkinson D, Newman W, Reid A, Squire S B, Sturm A W, Gilks C F. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis 2000; 4: 513-518. (Pubitemid 30409167)
18. Kampala Tuberculosis Program. Health Information System for Kampala City Council Authority. Kampala, Uganda: Kampala Tuberculosis Program, 2010.
19. Khan F A, Minion J, Pai M, et al. Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis 2010; 50: 1288-1299.
20. Jones-Lopez E C, Ayakaka I, Levin J, et al. Effectiveness of the standard WHO recommended retreatment regimen (Category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med 2011; 8: e1000427.
21. Seung K J, Omatayo D B, Keshavjee S, Furin J J, Farmer P E, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in southern Africa. PLoS ONE 2009; 4: e7186.
22. Kudjawu Y, Massari V, Sow O, Bah B, Larouzé B, Murray J F. Benefit of amoxicillin in differentiating between TB suspects whose initial AFB sputum smears are negative. Int J Tuberc Lung Dis 2006; 10: 441-446.
23. Glynn J R, Warndorff D K, Fine P E, Munthali M M, Sichone W, Ponnighaus J M. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Bull World Health Organ 1998; 76: 295-305. (Pubitemid 28394063)
24. Manabe Y C, Hermans S M, Lamorde M, Castelnuovo B, Mullins C D, Kuznik A. Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis. PLoS ONE 2012; 7: e39187.
25. Tupasi T E, Gupta R, Quelapio M I, et al. Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines. PLoS Med 2006; 3: e352.
26. Health Action International. A one-day snapshot of a medicine's price across 93 countries. Amsterdam, The Netherlands: HAI, 2010. http://www.haiweb. org/medicineprices/05012010/Global-briefing-note.pdf Accessed October 2012.
27. Dowdy D W, O'Brien M A, Bishai D. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2008; 12: 1021-1029.
28. Albert H. Economic analysis of the diagnosis of smear-negative pulmonary tuberculosis in South Africa: incorporation of a new rapid test, FASTPlaqueTB, into the diagnostic algorithm. Int J Tuberc Lung Dis 2004; 8: 240-247. (Pubitemid 38622933)
29. Gold M R, Siegel J E, Russell L B, Weinstein M C, eds. Coste effectiveness in health and medicine. New York, NY, USA: Oxford University Press, 1996.
30. Drummond M F, O'Brien B, Stoddart G L. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford, UK: Oxford University Press, 1997.
31. Guo N, Marra C A, Marra F, Moadebi S, Elwood R K, Fitz-Gerald J M. Health state utilities in latent and active tuberculosis. Value in Health 2008; 11: 1154-1161.
32. Shillcutt S D, Walker D G, Goodman C A, Mills A J. Coste effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics 2009; 27: 903-917.
33. Garber A M, Phelps C E. Economic foundations of cost-effectiveness analysis. J Health Econ 1997; 16: 1-31. (Pubitemid 27224092)
34. Briggs A H. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479-500. (Pubitemid 30398806)
35. Evans C A. GeneXpert: a game-changer for tuberculosis control? PLoS Med 2011; 8: e1001064.